TCL Archive Breast Cancer Survivors Who Take Aspirin Have 50% Reduced Risk Of Metastasis February 26, 2010
TCL Archive SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma September 29, 2006
TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI April 15, 1977
TCL Archive New Therapeutic Modalities In Testing For Patients With Carcinoid Syndrome November 28, 2003
